maintain weightloss from glp-1 slidell GIP Agonist Weight Management GLP-1 Plateaus: Why They Happen

Ludwig DS, Peterson KE, Gortmaker SL

Other obesity management approaches While GLP-1 RAs have demonstrated substantial efficacy in promoting weight loss, it is useful to first examine other treatment modalities in obesity management

[DOI] [PubMed] [Google Scholar] 24.Nyberg J, Jacobsson C, Anderson MF, Eriksson PS

TailorMed and Tennr are integrating referral automation with medication affordability tools for infusion centers and specialty pharmacies, aiming to address patient barriers earlier

Mankind has MKP10241, a small-molecule oral obesity drug, in Phase II in Australia

However, a recent placebo-controlled study [13] demonstrated that the DPP-4 inhibitor vildagliptin significantly improved glycaemia (with a lower incidence of hypoglycaemia) in patients with type 2 diabetes with long-standing disease (~15 years) and poor glycaemic control (HbA 1c ~8.4% [68 mmol/mol]) on large doses of insulin (~80 units daily)